• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过粘性桥组装B细胞淋巴瘤特异性内化适体-siRNA纳米颗粒的方法。

Methods for assembling B-cell lymphoma specific and internalizing aptamer-siRNA nanoparticles via the sticky bridge.

作者信息

Zhou Jiehua, Rossi John J, Shum Ka To

机构信息

Department of Molecular and Cellular Biology, Beckman Research Institute of City of Hope, 1500 East Duarte Road, Duarte, CA, USA.

出版信息

Methods Mol Biol. 2015;1297:169-85. doi: 10.1007/978-1-4939-2562-9_12.

DOI:10.1007/978-1-4939-2562-9_12
PMID:25896003
Abstract

Structured functional RNA entities, including aptamers and siRNAs, have amazing versatility in structure and function. These molecules can serve as powerful, attractive building blocks for the bottom-up assembly of complex nanostructures. Here, we describe novel cell-type specific and internalizing B-cell activating factor receptor (BAFF-R) aptamer-siRNA delivery systems for B-cell lymphoma therapy, in which both the aptamer and the Dicer substrate siRNA (DsiRNA) portions are conjugated through a "sticky bridge." The BAFF-R is overexpressed on the surface of B-cell malignancies, allowing binding and internalization of the aptamer-stick-siRNA nanoparticles. STAT3 siRNAs are encapsulated within the nanoparticles delivered by the BAFF-R aptamers and are localized to the cytoplasm, resulting in robust gene silencing of STAT3 mRNAs in a variety of B-cell lines. Moreover, these nanoparticles do not induce cell proliferation and apoptosis. Collectively, aptamer-mediated delivery strategies provide a toolset to become a more widely used therapeutic modality for the treatment of diseases.

摘要

包括适体和小干扰RNA(siRNA)在内的结构化功能性RNA实体在结构和功能上具有惊人的多功能性。这些分子可作为强大且有吸引力的构建模块,用于自下而上地组装复杂的纳米结构。在此,我们描述了用于B细胞淋巴瘤治疗的新型细胞类型特异性且可内化的B细胞活化因子受体(BAFF-R)适体-siRNA递送系统,其中适体和Dicer底物siRNA(DsiRNA)部分通过“粘性桥”连接。BAFF-R在B细胞恶性肿瘤表面过度表达,使得适体-粘性-siRNA纳米颗粒能够结合并内化。STAT3 siRNA被封装在由BAFF-R适体递送的纳米颗粒中,并定位于细胞质,从而在多种B细胞系中导致STAT3 mRNA的强效基因沉默。此外,这些纳米颗粒不会诱导细胞增殖和凋亡。总体而言,适体介导的递送策略提供了一套工具,有望成为一种更广泛应用于疾病治疗的治疗方式。

相似文献

1
Methods for assembling B-cell lymphoma specific and internalizing aptamer-siRNA nanoparticles via the sticky bridge.通过粘性桥组装B细胞淋巴瘤特异性内化适体-siRNA纳米颗粒的方法。
Methods Mol Biol. 2015;1297:169-85. doi: 10.1007/978-1-4939-2562-9_12.
2
Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cells.双功能 BAFF 受体适体抑制配体诱导的增殖并将 siRNAs 递送至 NHL 细胞。
Nucleic Acids Res. 2013 Apr;41(7):4266-83. doi: 10.1093/nar/gkt125. Epub 2013 Mar 6.
3
Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition.含有 phi29 马达 pRNA 和抗 gp120 适体的双重功能 RNA 纳米颗粒,用于细胞类型特异性递送和 HIV-1 抑制。
Methods. 2011 Jun;54(2):284-94. doi: 10.1016/j.ymeth.2010.12.039. Epub 2011 Jan 20.
4
Aptamer-targeted RNAi for HIV-1 therapy.适体靶向RNA干扰用于HIV-1治疗。
Methods Mol Biol. 2011;721:355-71. doi: 10.1007/978-1-61779-037-9_22.
5
Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy.用于HIV-1治疗的新型双抑制功能适配体-siRNA递送系统。
Mol Ther. 2008 Aug;16(8):1481-9. doi: 10.1038/mt.2008.92. Epub 2008 May 6.
6
Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells.抗粘蛋白1适配体偶联壳聚糖纳米粒用于多西他赛和IGF-1R siRNA靶向共递送以作用于SKBR3转移性乳腺癌细胞
Iran Biomed J. 2019 Jan;23(1):21-33. doi: 10.29252/.23.1.21. Epub 2018 Jul 25.
7
Functional assays for specific targeting and delivery of RNA nanoparticles to brain tumor.用于将RNA纳米颗粒特异性靶向递送至脑肿瘤的功能测定
Methods Mol Biol. 2015;1297:137-52. doi: 10.1007/978-1-4939-2562-9_10.
8
Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.用于治疗乳腺癌的适配体功能化杂化纳米颗粒。
Eur J Pharm Biopharm. 2017 May;114:108-118. doi: 10.1016/j.ejpb.2017.01.011. Epub 2017 Jan 25.
9
Development of cell-type specific anti-HIV gp120 aptamers for siRNA delivery.用于小干扰RNA递送的细胞类型特异性抗HIV gp120适配体的研发。
J Vis Exp. 2011 Jun 23(52):2954. doi: 10.3791/2954.
10
CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells.CTLA4适配体将STAT3小干扰RNA递送至肿瘤相关T细胞和恶性T细胞。
J Clin Invest. 2014 Jul;124(7):2977-87. doi: 10.1172/JCI73174. Epub 2014 Jun 2.

引用本文的文献

1
The Research Advances of Aptamers in Hematologic Malignancies.适体在血液系统恶性肿瘤中的研究进展
Cancers (Basel). 2023 Jan 1;15(1):300. doi: 10.3390/cancers15010300.
2
The Roles of Sclerostin in Immune System and the Applications of Aptamers in Immune-Related Research.骨硬化蛋白在免疫系统中的作用及适体在免疫相关研究中的应用。
Front Immunol. 2021 Feb 25;12:602330. doi: 10.3389/fimmu.2021.602330. eCollection 2021.
3
Combined Targeting of Glioblastoma Stem-Like Cells by Neutralizing RNA-Bio-Drugs for STAT3.通过中和针对STAT3的RNA生物药物联合靶向胶质母细胞瘤干细胞样细胞
Cancers (Basel). 2020 May 31;12(6):1434. doi: 10.3390/cancers12061434.
4
Potential and Challenges of Aptamers as Specific Carriers of Therapeutic Oligonucleotides for Precision Medicine in Cancer.适体作为治疗性寡核苷酸的特异性载体在癌症精准医学中的潜力与挑战
Cancers (Basel). 2019 Oct 10;11(10):1521. doi: 10.3390/cancers11101521.
5
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma.适体-小干扰RNA嵌合体介导的信号转导和转录激活因子3基因沉默作为胶质母细胞瘤的选择性治疗方法
Mol Ther Nucleic Acids. 2018 Mar 2;10:398-411. doi: 10.1016/j.omtn.2017.12.021. Epub 2017 Dec 30.